Êåòî-íàâèãàòîð - ÷èòàòü îíëàéí êíèãó. Àâòîð: Äæîçåô Ìåðêîëà, Äæåéìñ ÄèÍèêîëàíòîíèî còð.¹ 69

÷èòàòü êíèãè îíëàéí áåñïëàòíî
 
 

Îíëàéí êíèãà - Êåòî-íàâèãàòîð | Àâòîð êíèãè - Äæîçåô Ìåðêîëà , Äæåéìñ ÄèÍèêîëàíòîíèî

Còðàíèöà 69
÷èòàòü îíëàéí êíèãè áåñïëàòíî

28. Rodgers B. Feeding in infancy and later ability and attainment: a longitudinal study. Dev Med Child Neurol. 1978 Aug; 20 (4): 421–426.

29. Taylor B, Wadsworth J. Breast feeding and child development at five years. Dev Med Child Neurol. 1984 Feb; 26 (1): 73–80.

30. Rogan WJ, Gladen BC. Breast-feeding and cognitive development. Early Hum Dev. 1993 Jan; 31 (3): 181–193.

31. Horwood LJ, Fergusson DM. Breastfeeding and later cognitive and academic outcomes. Pediatrics. 1998 Jan; 101 (1): E9.

32. Lanting CI, Fidler V, Huisman M, et al. Neurological differences between 9-yearold children fed breast-milk or formula-milk as babies. Lancet. 1994 Nov 12; 344 (8933): 1319–1322.

33. Menkes JH. Early feeding history of children with learning disorders. Dev Med Child Neurol. 1977 Apr; 19 (2): 169–171.

34. Rodgers B. Feeding in infancy and later ability and attainment: a longitudinal study. Dev Med Child Neurol. 1978 Aug; 20 (4): 421–426.

35. Taylor B, Wadsworth J. Breast feeding and child development at five years. Dev Med Child Neurol. 1984 Feb; 26 (1): 73–80.

36. Hornstra G. Essential fatty acids in mothers and their neonates. Am J Clin Nutr. 2000 May; 71(5 Suppl): 1262s–1269s.

37. Popeski D, Ebbeling LR, Brown PB, et al. Blood pressure during pregnancy in Canadian Inuit: community differences related to diet. CMAJ. 1991 Sep 1; 145 (5): 445–454.

38. Williams MA, Zingheim RW, King IB, et al. Omega-3 fatty acids in maternal erythrocytes and risk of preeclampsia. Epidemiology. 1995 May; 6 (3): 232–237.

39. Òàì æå.

40. Onwude JL, Lilford RJ, Hjartardottir H, et al. A randomised double blind placebo controlled trial of fish oil in high risk pregnancy. Br J Obstet Gynaecol. 1995 Feb; 102 (2): 95–100.

41. Logan AC. Neurobehavioral aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression. Altern Med Rev. 2003 Nov; 8 (4): 410–425.

42. Klerman GL, Weissman MM. Increasing rates of depression. JAMA.1989 Apr 21; 261 (15): 2229–2235.

43. Kornstein SG, Schneider RK. Clinical features of treatment-resistant depression. J Clin Psychiatry. 2001; 62 Suppl 16: 18–25.

44. Lin PY, Huang SY, Su KP. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry. 2010 Jul 15; 68 (2): 140–147.

45. Tanskanen A, Hibbeln JR, Tuomilehto J, et al. Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv. 2001 Apr; 52 (4): 529–531.

46. Maes M, Smith RS. Fatty acids, cytokines, and major depression. Biol Psychiatry. 1998 Mar 1; 43 (5): 313–314.

47. Òàì æå.

48. Mazereeuw G, Lanctot KL, Chau SA, et al. Effects of omega-3 fatty acids on cognitive performance: a meta-analysis. Neurobiol Aging. 2012 Jul; 33(7): 1482.e17–29.

49. Xia Z, DePierre JW, Nassberger L. Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferongamma in T cells. Immunopharmacology. 1996 Aug; 34 (1): 27–37.

50. Serhan CN, Arita M, Hong S, et al. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids. 2004 Nov; 39 (11): 1125–1132.

51. Hibbeln JR. Fish consumption and major depression. Lancet. 1998 Apr 18; 351 (9110): 1213.

52. Hibbeln JR, Gow RV. The potential for military diets to reduce depression, suicide, and impulsive aggression: a review of current evidence for omega-3 and omega-6 fatty acids. Mil Med. 2014 Nov; 17911 Suppl): 117–128.

53. Tanskanen A, Hibbeln JR, Tuomilehto J, et al. Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv. 2001 Apr; 52 (4): 529–531.

54. Silvers KM, Scott KM. Fish consumption and self-reported physical and mental health status. Public Health Nutr. 2002 Jun; 5 (3): 427–431.

55. Adams PB, Lawson S, Sanigorski A, et al. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids. 1996 Mar; 31 Suppl: S157–161.

56. Tiemeier H, van Tuijl HR, Hofman A, et al. Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am J Clin Nutr. 2003 Jul; 78 (1): 40–46.

57. Mamalakis G, Tornaritis M, Kafatos A. Depression and adipose essential polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids. 2002 Nov; 67 (5): 311–318.

58. Hibbeln JR. Seafood consumption, the DHA content of mothers’ milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord. 2002 May; 69 (1–3): 15–29.

59. Mazereeuw G, Lanctot KL, Chau SA, et al. Effects of omega-3 fatty acids on cognitive performance: a meta-analysis. Neurobiol Aging. 2012 Jul; 33 (7): 1482.e17–29.

60. Òàì æå.

61. Òàì æå.

62. Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry. 2002 Mar; 159 (3): 477–479.

63. Su KP, Huang SY, Chiu CC, et al. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol. 2003 Aug; 13 (4): 267–271.

64. Lin PY, Huang SY, Su KP. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry. 2010 Jul 15; 68 (2): 140–147.

65. Grosso G, Pajak A, Marventano S, et al. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS One. 2014; 9 (5): e96905.

66. Nemets B, Stahl Z, Belmaker RH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry. 2002 Mar; 159 (3): 477–479.

67. Peet M, Horrobin DF. A dose-ranging study of the effects of ethyleicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry. 2002 Oct; 59 (1): 913–919.

68. Frangou S, Lewis M, McCrone P. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br J Psychiatry. 2006 Jan; 188: 46–50.

69. Nemets H, Nemets B, Apter A, et al. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am J Psychiatry. 2006 Jun; 163 (6): 1098–1100.

Âåðíóòüñÿ ê ïðîñìîòðó êíèãè Ïåðåéòè ê Îãëàâëåíèþ Ïåðåéòè ê Ïðèìå÷àíèþ